$34.39 0.19 (0.56%)
19:59 EST PFE Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 201.17B
PE Ratio 9.55
Volume (Avg. Vol.) 30.59M
Day's Range 33.96 - 34.55
52-Week Range 27.88 - 43.08
Dividend & Yield 1.56 (4.54%)
PFE Stock Predictions, Articles, and Pfizer News
- From InvestorPlace
- From the Web
The remote economy has served as a tailwind for numerous mega-cap stocks that show a lot of future growth potential. Here are 7 stocks worth buying this year.
By Thomas Niel
What are some examples of "cheap stocks" in today's still-strong stock market? These 9 may be great value plays to consider. Best Buy (NYSE:BBY) DaVita (NYSE:DVA) DXC Technology (NYSE:DXC) Fox Corporation (NASDAQ:FOX) Lumen Technologies (NYSE:LUMN) Altria Group (NYSE:MO) Pfizer (NYSE:PFE) Sprouts Farmers Market (NASDAQ:SFM) Verizon Communications (NYSE:VZ)
By Joel Baglole
Several tried and true blue-chip stocks that performed well during the past year are starting to look a little pale lately. Is this a temporary downturn or the start of worsening trend? In this article, we look at seven blue-chip stocks that look a little pale.
By Thomas Niel
Which dividend stocks should you consider for both 3%+ yields and the potential for appreciation? These nine names come to mind. Cardinal Health (NYSE:CAH) Conagra Brands (NYSE:CAG) IBM (NYSE:IBM) Kellogg (NYSE:K) Kimberly-Clark (NYSE:KMB) Lockheed Martin (NYSE:LMT) Pfizer (NYSE:PFE) Phillip Morris International (NYSE:PM) PPL Corporation (NYSE:PPL)
These cheap stocks are ready to rally as markets look for value. Each is fundamentally strong for a near-term trade and long-term investment.
These 5 stocks are great stocks to buy in any future market crash, as they all have good fundamentals and great long-term prospects.
When starting out, it’s probably best to look at quality. Here are seven familiar names for new investors to consider.
Investors are enamored with high profile stocks and ignoring ones that are solid investments. Here are three biotech stocks to consider.
Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.
The vaccine will be a key. But there are other growth drivers for Pfizer stock.
With 2020's proof in hand, it won't razzle dazzle Wall Street, but make no mistake, Pfizer stock can breathe life into investors portfolios
No need to let Covid-19 vaccine distribution issues deter you from owning Pfizer stock as the company still stands to earn massive revenues.
Pfizer stock was earlier a key benefactor from the coronavirus vaccine race, but a new perceptional risk is weighing on shares.
Pfizer stock is down slightly so far this year despite an attractive valuation, high dividend yield and solid outlook. It's a value play.
By Joel Baglole
Pharmaceutical stocks, such as Moderna and Novavaxsaw their share prices more than double in the last year. However, not all pharmaceutical stocks have their wagons hitched to solving the Covid-19 pandemic. There are many pharmaceutical stocks that are great long-term investments and would be good additions to a portfolio in any environment. Here we look at four such pharmaceutical stocks.
PFE stock never enjoyed the same run-up in the Covid-19 vaccine race as its competitors, even though it crossed the finish line first.
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.
Navellier RatingsPowered by Portfolio Grader